All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group

Buyside appetite in OTC derivatives remains undiminished

Sponsored Euroclear.png
euroclear logo

Like most major regulatory changes, the introduction of new margin, collateral and capital requirements for non-cleared OTC derivatives has been subject to delay as regulators finalise the details and dealers are struggling with their implementation. With its global start date already having been delayed from Q3 2015 to 2016, Europe is now pushing back further, most likely to Q2 1017.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree